“Posting a preprint to bioRxiv is extremely beneficial: it gets the results to our community faster so we can accelerate progress. It also clearly provides an initial metric of the interest in and impact of our findings. Coupled with publication in PLOS Pathogens and its rigorous review process, our colleagues can quickly benefit from, and have confidence in, the discoveries and our interpretations.”